DESOFAM
Generic name not specified · by ZAFA
Composition
Tab: Ethinyloestradiol 0.03 mg and Desogestrel 0.15 mg.
Indications & Dosage
Oral contraception: Females of childbearing potential: 1 tab daily without interruption. Children: Not recommended.
Contraindications
Hormone dependent carcinoma, pregnancy, acute porphyrias, severe arterial disease, undiagnosed vaginal bleeding, history of breast cancer but can be used after 5 years if no evidence of disease and non-hormonal contraceptive methods unacceptable
Precautions
Severe depression, diabetes, active trophoblastic disease (until return to normal of urine- and plasma-gonadotrophin concentration), arterial disease, functional ovarian cysts, history of jaundice in pregnancy, malabsorption syndromes, past ectopic pregnancy, sexsteroid dependent cancer, systemic lupus erythematosus with positive (or unknown) antiphospholipid antibodies While using as contraceptive wait 6 weeks post-partum if lactating, risk of breast cancer, history during pregnancy in disturbances of lipid metabolism or deterioration of otosclerosis or pruritus
Side Effects
Breast discomfort, depression, dizziness, headache, indigestion, loss of vision during treatment (discontinue treatment if papill oedema or retinal vascular lesions), menstrual irregularities, nausea, pruritus, vomiting, weight gain, disturbance of appetite, injection site-reactions, reduced bone mineral density, skin disorders. Rare: Osteoporosis, osteoporotic fractures